🔗 Visit the ClinicalTrials.gov page for NCT04567459
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. | J Clin Oncol | 2009 | 9.24 |
| 2 | Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. | J Am Med Dir Assoc | 2014 | 2.92 |
| 3 | Incidence and survival of adult cancer patients in Taiwan, 2002-2012. | J Formos Med Assoc | 2016 | 0.98 |
| 4 | Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. | Support Care Cancer | 2014 | 0.94 |
| 5 | Inflammation and sarcopenia: A systematic review and meta-analysis. | Maturitas | 2016 | 0.78 |
| 6 | Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. | Cancer | 2016 | 0.77 |